Ted Vandenberg
YOU?
Author Swipe
View article: Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial
Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial Open
Objective To evaluate the effectiveness of remote proactive management of toxicities during chemotherapy for early stage breast cancer. Design Pragmatic, cluster randomised trial. Setting 20 cancer centres in Ontario, Canada, allocated by …
View article: Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer Open
The addition of fulvestrant to anastrozole was associated with increased long-term survival as compared with anastrozole alone, despite substantial crossover to fulvestrant after progression during therapy with anastrozole alone. The resul…
View article: Everolimus in advanced breast cancer: A systematic review and meta-analysis
Everolimus in advanced breast cancer: A systematic review and meta-analysis Open
Background: Everolimus (E) plus exemestane are approved for advanced hormone receptor (+) breast cancer (BC) after progression on non-steroidal aromatase inhibitors. The role of E is less well defined in other BC phenotypes and with other …
View article: Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226 Open
Aims In the SWOG S0226 trial the combination of anastrozole plus fulvestrant ( n = 349) was superior to anastrozole alone ( n = 345) in hormone receptor (HR)‐positive metastatic breast cancer. Here we report a pharmacokinetic subset analys…